ACCSL
gene geneOn this page
Summary
ACCSL (1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like, HGNC:34391) is a protein-coding gene on chromosome 11p11.2, encoding Probable inactive 1-aminocyclopropane-1-carboxylate synthase-like protein 2 (Q4AC99).
Predicted to enable transaminase activity. Predicted to be involved in amino acid metabolic process.
Source: NCBI Gene 390110 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 91 total — 1 pathogenic
- MANE Select transcript:
NM_001031854
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34391 |
| Approved symbol | ACCSL |
| Name | 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) like |
| Location | 11p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000205126 |
| Ensembl biotype | protein_coding |
| Entrez | 390110 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 nonsense_mediated_decay
ENST00000378832, ENST00000527145
RefSeq mRNA: 2 — MANE Select: NM_001031854
NM_001031854, NM_001363113
CCDS: CCDS41636
Canonical transcript exons
ENST00000378832 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001478892 | 44059838 | 44059977 |
| ENSE00001478914 | 44050062 | 44050121 |
| ENSE00001478916 | 44047981 | 44048540 |
| ENSE00003489752 | 44052991 | 44053068 |
| ENSE00003493368 | 44058546 | 44058699 |
| ENSE00003494818 | 44053406 | 44053506 |
| ENSE00003507044 | 44052662 | 44052759 |
| ENSE00003510117 | 44055202 | 44055291 |
| ENSE00003595394 | 44051653 | 44051719 |
| ENSE00003620025 | 44056040 | 44056085 |
| ENSE00003645274 | 44056185 | 44056326 |
| ENSE00003658545 | 44050552 | 44050622 |
| ENSE00003661166 | 44058317 | 44058459 |
| ENSE00003665395 | 44051335 | 44051404 |
Expression profiles
Bgee: expression breadth broad, 17 present calls, max score 83.76.
Top tissues by expression
107 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.76 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 57.10 | silver quality |
| monocyte | CL:0000576 | 56.76 | gold quality |
| leukocyte | CL:0000738 | 56.01 | gold quality |
| sural nerve | UBERON:0015488 | 41.33 | gold quality |
| stromal cell of endometrium | CL:0002255 | 39.29 | gold quality |
| bone marrow cell | CL:0002092 | 38.55 | gold quality |
| granulocyte | CL:0000094 | 37.42 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| skin of leg | UBERON:0001511 | 37.15 | silver quality |
| zone of skin | UBERON:0000014 | 36.53 | silver quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| mucosa of stomach | UBERON:0001199 | 36.25 | silver quality |
| bone marrow | UBERON:0002371 | 35.52 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| right coronary artery | UBERON:0001625 | 34.99 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 34.79 | gold quality |
| placenta | UBERON:0001987 | 34.70 | gold quality |
| testis | UBERON:0000473 | 34.42 | gold quality |
| ectocervix | UBERON:0012249 | 34.42 | silver quality |
| right testis | UBERON:0004534 | 34.37 | silver quality |
| right uterine tube | UBERON:0001302 | 34.10 | gold quality |
| left testis | UBERON:0004533 | 33.96 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 33.46 | gold quality |
| muscle tissue | UBERON:0002385 | 33.43 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| cerebellar cortex | UBERON:0002129 | 32.27 | gold quality |
| cerebellum | UBERON:0002037 | 32.24 | gold quality |
| left uterine tube | UBERON:0001303 | 32.21 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.27 |
Regulation
Is transcription factor: no
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Accsl | ENSMUSG00000075023 |
| drosophila_melanogaster | CG1640 | FBGN0030478 |
| drosophila_melanogaster | CG6321 | FBGN0036117 |
| caenorhabditis_elegans | WBGENE00009232 | |
| caenorhabditis_elegans | WBGENE00010984 | |
| caenorhabditis_elegans | WBGENE00011436 | |
| caenorhabditis_elegans | C32F10.8 | WBGENE00016333 |
Paralogs (7): AADAT (ENSG00000109576), ACCS (ENSG00000110455), KYAT3 (ENSG00000137944), GPT2 (ENSG00000166123), GPT (ENSG00000167701), KYAT1 (ENSG00000171097), TAT (ENSG00000198650)
Protein
Protein identifiers
Probable inactive 1-aminocyclopropane-1-carboxylate synthase-like protein 2 — Q4AC99 (reviewed: Q4AC99)
All UniProt accessions (2): E9PI59, Q4AC99
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the class-I pyridoxal-phosphate-dependent aminotransferase family.
RefSeq proteins (2): NP_001027025, NP_001350042 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004839 | Aminotransferase_I/II_large | Domain |
| IPR015421 | PyrdxlP-dep_Trfase_major | Homologous_superfamily |
| IPR015422 | PyrdxlP-dep_Trfase_small | Homologous_superfamily |
| IPR015424 | PyrdxlP-dep_Trfase | Homologous_superfamily |
| IPR050478 | Ethylene_sulfur-biosynth | Family |
Pfam: PF00155
UniProt features (10 total): sequence conflict 6, chain 1, region of interest 1, modified residue 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q4AC99-F1 | 84.52 | 0.68 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 395
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 24 (showing top):
GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS, GOMF_VITAMIN_BINDING, YOSHIMURA_MAPK8_TARGETS_UP, MIKKELSEN_MCV6_ICP_WITH_H3K27ME3, GOMF_VITAMIN_B6_BINDING, GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN, GSE11924_TH2_VS_TH17_CD4_TCELL_UP, GSE14350_IL2RB_KO_VS_WT_TREG_UP, GSE18148_CBFB_KO_VS_WT_TREG_DN, GOMF_TRANSAMINASE_ACTIVITY, GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP, GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN, GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_UP, GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN, GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP
GO Biological Process (2): amino acid metabolic process (GO:0006520), biosynthetic process (GO:0009058)
GO Molecular Function (2): transaminase activity (GO:0008483), pyridoxal phosphate binding (GO:0030170)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| primary metabolic process | 1 |
| metabolic process | 1 |
| transferase activity, transferring nitrogenous groups | 1 |
| anion binding | 1 |
| vitamin B6 binding | 1 |
Protein interactions and networks
STRING
1369 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ACCSL | OR51B2 | Q9Y5P1 | 418 |
| ACCSL | DEFB112 | Q30KQ8 | 412 |
| ACCSL | ST8SIA3 | O43173 | 411 |
| ACCSL | SLC15A5 | A6NIM6 | 400 |
| ACCSL | TMEM255B | Q8WV15 | 395 |
| ACCSL | DMRTC2 | Q8IXT2 | 394 |
| ACCSL | WDR38 | Q5JTN6 | 381 |
| ACCSL | AIPL1 | Q9NZN9 | 379 |
| ACCSL | BTG4 | Q9NY30 | 377 |
| ACCSL | PATL2 | C9JE40 | 369 |
| ACCSL | AASDH | Q4L235 | 353 |
| ACCSL | ALDH18A1 | P54886 | 352 |
| ACCSL | TCF23 | Q7RTU1 | 346 |
| ACCSL | ASB9 | Q96DX5 | 342 |
| ACCSL | MOCOS | Q96EN8 | 340 |
IntAct
0 interactions, top by confidence:
BioGRID (2): ACCSL (Synthetic Lethality), ACCSL (Affinity Capture-MS)
ESM2 similar proteins: A0A1L1SUL6, F1LQY6, O35465, O43379, O75293, O88910, O88954, P0C0T1, P21964, P22339, P41214, P50747, Q13368, Q13572, Q14318, Q16342, Q1HAQ0, Q28955, Q2T9Z1, Q3B7U9, Q3TFD2, Q3TMX7, Q496Y0, Q4AC99, Q5BIM1, Q5E9A5, Q5R812, Q5RA63, Q5SZD4, Q64311, Q6DC64, Q6P5G6, Q6PFY8, Q80YV4, Q8BNV1, Q8BYN3, Q8NFZ0, Q8R1C6, Q8R1T1, Q8TCU6
Diamond homologs: A0A0P0UZP7, A0A0P0WIY3, A2XLL2, P18485, P23279, P23599, P27486, P29535, P31531, P36692, P37821, Q00257, Q00379, Q01912, Q03VY3, Q06402, Q06429, Q07262, Q0CS62, Q10DK7, Q37001, Q42881, Q43309, Q4AC99, Q5W6F9, Q6Q887, Q7XQ85, Q8GYY0, Q9LQ10, Q9M2Y8, Q9MB95, Q9S9U6, Q9SAR0, Q9SNN8, Q9STR4, Q9T065, A2AIG8, Q3UX83, Q5E9H2, Q96QU6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
91 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 82 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 148316 | GRCh38/hg38 11p12-11.12(chr11:39179252-49135735)x1 | Pathogenic |
SpliceAI
1732 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:44050119:AGA:A | donor_gain | 1.0000 |
| 11:44050120:GA:G | donor_gain | 1.0000 |
| 11:44050120:GAG:G | donor_gain | 1.0000 |
| 11:44050122:G:GG | donor_gain | 1.0000 |
| 11:44050127:G:GT | donor_gain | 1.0000 |
| 11:44050550:A:AG | acceptor_gain | 1.0000 |
| 11:44050551:G:GG | acceptor_gain | 1.0000 |
| 11:44050623:G:GG | donor_gain | 1.0000 |
| 11:44051647:CTTCA:C | acceptor_loss | 1.0000 |
| 11:44051648:TTCAG:T | acceptor_loss | 1.0000 |
| 11:44051649:TCAG:T | acceptor_loss | 1.0000 |
| 11:44051650:CA:C | acceptor_loss | 1.0000 |
| 11:44051716:GGCG:G | donor_gain | 1.0000 |
| 11:44051717:GCGG:G | donor_gain | 1.0000 |
| 11:44052987:CCAG:C | acceptor_loss | 1.0000 |
| 11:44052988:CA:C | acceptor_loss | 1.0000 |
| 11:44052989:A:AC | acceptor_loss | 1.0000 |
| 11:44052989:A:AG | acceptor_gain | 1.0000 |
| 11:44052990:G:GG | acceptor_gain | 1.0000 |
| 11:44052990:G:GT | acceptor_loss | 1.0000 |
| 11:44052990:GGT:G | acceptor_gain | 1.0000 |
| 11:44052990:GGTC:G | acceptor_gain | 1.0000 |
| 11:44052990:GGTCA:G | acceptor_gain | 1.0000 |
| 11:44053068:GGTAA:G | donor_loss | 1.0000 |
| 11:44053070:T:G | donor_loss | 1.0000 |
| 11:44053401:CTTA:C | acceptor_loss | 1.0000 |
| 11:44053402:TTA:T | acceptor_loss | 1.0000 |
| 11:44053404:A:AG | acceptor_gain | 1.0000 |
| 11:44053404:AGG:A | acceptor_gain | 1.0000 |
| 11:44053405:G:A | acceptor_loss | 1.0000 |
AlphaMissense
3756 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:44050612:G:A | G209R | 0.947 |
| 11:44050612:G:C | G209R | 0.947 |
| 11:44050612:G:T | G209W | 0.947 |
| 11:44058657:T:C | F528L | 0.944 |
| 11:44058659:C:A | F528L | 0.944 |
| 11:44058659:C:G | F528L | 0.944 |
| 11:44051660:T:A | V238D | 0.935 |
| 11:44050613:G:A | G209E | 0.927 |
| 11:44053496:T:C | F347L | 0.921 |
| 11:44053498:T:A | F347L | 0.921 |
| 11:44053498:T:G | F347L | 0.921 |
| 11:44051340:G:C | R214P | 0.917 |
| 11:44056219:T:C | L407P | 0.917 |
| 11:44058669:T:C | F532L | 0.904 |
| 11:44058671:T:A | F532L | 0.904 |
| 11:44058671:T:G | F532L | 0.904 |
| 11:44051654:T:A | V236E | 0.903 |
| 11:44055248:T:C | F366L | 0.903 |
| 11:44055250:T:A | F366L | 0.903 |
| 11:44055250:T:G | F366L | 0.903 |
| 11:44051351:G:C | A218P | 0.900 |
| 11:44051357:T:C | F220L | 0.897 |
| 11:44051359:C:A | F220L | 0.897 |
| 11:44051359:C:G | F220L | 0.897 |
| 11:44056219:T:G | L407R | 0.890 |
| 11:44056295:G:C | Q432H | 0.890 |
| 11:44056295:G:T | Q432H | 0.890 |
| 11:44058412:T:C | F475L | 0.879 |
| 11:44058414:T:A | F475L | 0.879 |
| 11:44058414:T:G | F475L | 0.879 |
dbSNP variants (sampled 300 via entrez): RS1000021892 (11:44020252 A>G), RS1000031004 (11:44007918 TA>T), RS1000034707 (11:43927272 G>A), RS1000042761 (11:43982532 C>T), RS1000043997 (11:44048836 G>A,C), RS1000142690 (11:44055347 G>C), RS1000158543 (11:43956070 C>A,T), RS1000179390 (11:44038372 A>T), RS1000186486 (11:43919366 C>G,T), RS1000245668 (11:43965369 A>C), RS1000305145 (11:43925221 C>T), RS1000307409 (11:44026745 T>C), RS1000329059 (11:43952605 C>T), RS1000332301 (11:43952104 T>C), RS1000336354 (11:43945317 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007096_12 | Pulse pressure | 1.000000e-09 |
| GCST007269_196 | Pulse pressure | 1.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005763 | pulse pressure measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases methylation | 2 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.